Odyssey - Alternative

• Research type

  Research Study

• Full title

  A Randomized, Double-Blind, Double-Dummy, Active-Controlled Study to Evaluate the Efficacy and Safety of REGN727/SAR236553 in Patients with Primary Hypercholesterolemia Who are Intolerant to Statins

• IRAS ID

  120754

• Contact name

  Adie Viljoen

• Contact email

  adie.viljoen@nhs.net

• Sponsor organisation

  Regeneron Pharmaceuticals, Inc.

• Eudract number

  2012-001221-27

• REC name

  London - Fulham Research Ethics Committee

• REC reference

  13/LO/0383

• Date of REC Opinion

  29 Apr 2013

• REC opinion

  Further Information Favourable Opinion